Kiyohiro Takigiku
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kiyohiro Takigiku has a total of 102 co-authors. Here are the top co-authors by number of shared publications:
Kohta Takei
Department of Pediatric Cardiology, Nagano Children's Hospital, 3100 Toyoshina, Azumino, Nagano, 399-8288, Japan
4 shared publicationsYohei Akazawa
Department of Pediatric Cardiology, Nagano Children's Hospital, 3100 Toyoshina, Azumino, Nagano, 399-8288, Japan
4 shared publicationsHaruka Obinata
Department of Pediatric Cardiology, Nagano Children's Hospital, 3100 Toyoshina, Azumino, Nagano, 399-8288, Japan
3 shared publicationsRyusuke Numata
Department of Pediatric Cardiology, Nagano Children’s Hospital, Toyoshina, Azumino, Nagano, Japan
3 shared publicationsYuma Shibuya
Department of Pediatric Cardiology, Nagano Children's Hospital, 3100 Toyoshina, Azumino, Nagano, 399-8288, Japan
3 shared publicationsAi Kojima
Department of Pediatric Cardiovascular Surgery, Nagano Children’s Hospital, Toyoshina, Azumino, Nagano, Japan
2 shared publications
Latest Publications
- 28 May 2026
- Published by Springer Nature in Pediatric Radiology
- Vol. 56 (10) , 2238-2248
Super-resolution deep learning reconstruction achieves low-dose high-resolution imaging in pediatric cardiac computed tomography
Cardiac computed tomography (CT) is widely utilized in pediatric cardiology, but minimizing radiation exposure is essential. Recently, super-resolution deep learning reconstruction (SR-DLR) has emerged as a potential advancement over conventional deep learning reconstruction (C-DLR). To evaluate the potential of SR-DLR for further radiation dose reduction in pediatric cardiac CT through a comparison with C-DLR. The phantom-based study assessed noise power spectrum and spatial resolution. For the clinical study, we compared nine C-DLR images (conventional radiation dose) and 11 SR-DLR images (lower radiation dose). Evaluation metrics included noise levels, contrast-to-noise ratio, and edge rise distance and edge rise slope. In the phantom-based study, SR-DLR (250 mA) displayed equivalent noise characteristics as C-DLR (800 mA) while achieving superior spatial resolution. In clinical images, preliminary comparisons within the high-dose group revealed that SR-DLR significantly outperformed C-DLR in spatial resolution metrics, specifically edge rise distance and edge rise slope (P<0.001). Furthermore, despite the lower radiation dose used for SR-DLR than for C-DLR (volume CT dose index, 4.25±0.54 mGy vs. 13.3±6.43 mGy), there were no significant differences in noise, contrast resolution, and spatial resolution between the groups. SR-DLR maintains non-inferior image quality compared with C-DLR even at reduced radiation doses. These findings substantiate the potential for further dose reduction in pediatric cardiac CT without compromising image quality.
- 28 May 2026
- Published by Springer Nature in Pediatric Radiology
- Vol. 56 (10) , 2238-2248
Super-resolution deep learning reconstruction achieves low-dose high-resolution imaging in pediatric cardiac computed tomography
Cardiac computed tomography (CT) is widely utilized in pediatric cardiology, but minimizing radiation exposure is essential. Recently, super-resolution deep learning reconstruction (SR-DLR) has emerged as a potential advancement over conventional deep learning reconstruction (C-DLR). To evaluate the potential of SR-DLR for further radiation dose reduction in pediatric cardiac CT through a comparison with C-DLR. The phantom-based study assessed noise power spectrum and spatial resolution. For the clinical study, we compared nine C-DLR images (conventional radiation dose) and 11 SR-DLR images (lower radiation dose). Evaluation metrics included noise levels, contrast-to-noise ratio, and edge rise distance and edge rise slope. In the phantom-based study, SR-DLR (250 mA) displayed equivalent noise characteristics as C-DLR (800 mA) while achieving superior spatial resolution. In clinical images, preliminary comparisons within the high-dose group revealed that SR-DLR significantly outperformed C-DLR in spatial resolution metrics, specifically edge rise distance and edge rise slope (P<0.001). Furthermore, despite the lower radiation dose used for SR-DLR than for C-DLR (volume CT dose index, 4.25±0.54 mGy vs. 13.3±6.43 mGy), there were no significant differences in noise, contrast resolution, and spatial resolution between the groups. SR-DLR maintains non-inferior image quality compared with C-DLR even at reduced radiation doses. These findings substantiate the potential for further dose reduction in pediatric cardiac CT without compromising image quality.
- 30 July 2025
- Published by Springer Nature in Journal of Echocardiography
- Vol. 23 (4) , 279-285
The impact of intraoperative pericardial three-dimensional echocardiography for the atrioventricular valve repair in pediatric patients of congenital heart disease
Purpose We performed intraoperative pericardial three-dimensional echocardiography (IP3DE) for atrioventricular valve (AVV) repair in patients with congenital heart disease. In this study, we retrospectively reviewed the surgical cases of AVV repair and assessed the impact of IP3DE. Methods We reviewed the medical records of patients who underwent AVV repair at Nagano Children’s Hospital. Patients were divided into two groups, the IP3DE group and the control group, which underwent two-dimensional transesophageal or transthoracic echocardiography. Clinical data, including the grade of regurgitation and re-intervention, were compared between the two groups. Results Forty-six patients in the IP3DE group and 35 in the control group were included. The preoperative median grade was 3 (maximum 2–minimum 4) and 3 (2–4) in the IP3DE and control groups, respectively. After surgery, median grade was decreased to 1 (1–4) and 2 (1–4) in the IP3DE and control groups, respectively. 80% and 54% of patients showed successful outcome (grade ≤ 2 after repair) in the IP3DE and control groups, respectively, which demonstrated that IP3DE contributed significantly to successful outcome (p < 0.05). Conclusions This study demonstrated, for the first time, the effectiveness of IP3DE in AVV repair in pediatric patients. IP3DE allows the visualization of clear 3D images and easy information sharing among cardiac vascular surgeons.
- 30 July 2025
- Published by Springer Nature in Journal of Echocardiography
- Vol. 23 (4) , 279-285
The impact of intraoperative pericardial three-dimensional echocardiography for the atrioventricular valve repair in pediatric patients of congenital heart disease
Purpose We performed intraoperative pericardial three-dimensional echocardiography (IP3DE) for atrioventricular valve (AVV) repair in patients with congenital heart disease. In this study, we retrospectively reviewed the surgical cases of AVV repair and assessed the impact of IP3DE. Methods We reviewed the medical records of patients who underwent AVV repair at Nagano Children’s Hospital. Patients were divided into two groups, the IP3DE group and the control group, which underwent two-dimensional transesophageal or transthoracic echocardiography. Clinical data, including the grade of regurgitation and re-intervention, were compared between the two groups. Results Forty-six patients in the IP3DE group and 35 in the control group were included. The preoperative median grade was 3 (maximum 2–minimum 4) and 3 (2–4) in the IP3DE and control groups, respectively. After surgery, median grade was decreased to 1 (1–4) and 2 (1–4) in the IP3DE and control groups, respectively. 80% and 54% of patients showed successful outcome (grade ≤ 2 after repair) in the IP3DE and control groups, respectively, which demonstrated that IP3DE contributed significantly to successful outcome (p < 0.05). Conclusions This study demonstrated, for the first time, the effectiveness of IP3DE in AVV repair in pediatric patients. IP3DE allows the visualization of clear 3D images and easy information sharing among cardiac vascular surgeons.
- 28 December 2024
- Published by Springer Nature in Journal of Echocardiography
- Vol. 23 (3) , 174-179
Usefulness of the “En face view” method for diagnosing perimembranous ventricular septal defects
Background Perimembranous ventricular septal defect (VSD) can be classified as having trabecular, inlet, or outlet extension. The surgical approach used in patch closure depends on the which valve of the tricuspid valve to suture around and the avoidance of the specialized conducting system. This retrospective study evaluated the usefulness of the “En face view” method for classifying perimembranous VSD. Methods We divided 147 patients with perimembranous VSD into one group of 52 patients diagnosed using the Helmcke et al. method until 2001 and another group of 95 patients diagnosed by the En face view method and conventional method from 2002. A definitive diagnosis was made intraoperatively for patients in whom the extension of the defect was examined using the En face view method during preoperative echocardiography. When the VSD extended towards the anterior leaflet from the commissure between the antero-septal commissure, it was considered outlet extension, and when it extended towards the septal leaflet, it was judged as inlet extension. Results Of the 52 patients in whom extension direction was diagnosed until 2001, the number of correct diagnoses was 39 (75.0%). Among the 95 patients who were diagnosed using En face view, a correct diagnosis was made in 84 (88.4%) patients (P = 0.035 vs. before En face view). Conclusions En face view allows the tricuspid valve to be visualized from the front, making it possible to accurately estimate the position of the perimembranous VSD and the positional relationship with the antero-septal commissure.
- 28 December 2024
- Published by Springer Nature in Journal of Echocardiography
- Vol. 23 (3) , 174-179
Usefulness of the “En face view” method for diagnosing perimembranous ventricular septal defects
Background Perimembranous ventricular septal defect (VSD) can be classified as having trabecular, inlet, or outlet extension. The surgical approach used in patch closure depends on the which valve of the tricuspid valve to suture around and the avoidance of the specialized conducting system. This retrospective study evaluated the usefulness of the “En face view” method for classifying perimembranous VSD. Methods We divided 147 patients with perimembranous VSD into one group of 52 patients diagnosed using the Helmcke et al. method until 2001 and another group of 95 patients diagnosed by the En face view method and conventional method from 2002. A definitive diagnosis was made intraoperatively for patients in whom the extension of the defect was examined using the En face view method during preoperative echocardiography. When the VSD extended towards the anterior leaflet from the commissure between the antero-septal commissure, it was considered outlet extension, and when it extended towards the septal leaflet, it was judged as inlet extension. Results Of the 52 patients in whom extension direction was diagnosed until 2001, the number of correct diagnoses was 39 (75.0%). Among the 95 patients who were diagnosed using En face view, a correct diagnosis was made in 84 (88.4%) patients (P = 0.035 vs. before En face view). Conclusions En face view allows the tricuspid valve to be visualized from the front, making it possible to accurately estimate the position of the perimembranous VSD and the positional relationship with the antero-septal commissure.
- Open Access
- 4 November 2024
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 13 (21) , e035614
Determination of Genotype and Phenotypes in Pediatric Patients With Biventricular Noncompaction
Background: Left ventricular noncompaction (LVNC) is a hereditary type of cardiomyopathy characterized by prominent trabeculations. Detailed characteristics of biventricular noncompaction (BiVNC) remain unknown. This study aimed to elucidate the clinical characteristics and genetic landscape of BiVNC. Methods and Results: We recruited children with left ventricular noncompaction from Japanese multi‐institutional centers from 2013 to 2021. Left ventricular noncompaction was classified as BiVNC, congenital heart disease, arrhythmia, dilated cardiomyopathy, or normal function. In these patients, cardiomyopathy‐associated genes were screened. A total of 234 patients (127 male; mean age, 4 months [range, 0–6.6 years]) were enrolled in this study, of whom 25 had BiVNC; 55, normal function; 84, dilated cardiomyopathy; 38, congenital heart disease; and 32, arrhythmia. BiVNC was diagnosed during the perinatal period in 10 patients, in whom the prevalence was higher than that in other patients. A total of 14 patients in the group with BiVNC had congenital heart disease, but not necessarily right heart lesions. Left ventricular dyskinesis was frequently observed in the lateral wall (24%) and apex (28%). Eleven pathogenic variants were found in 11 patients with BiVNC (44.0%). The group with BiVNC had a higher ratio of mitochondrial and developmental gene variants than the other groups. Among all groups, the group with BiVNC had the worst survival rate ( P =0.0009). Conclusions: Pediatric patients with BiVNC had a high rate of ventricular dyskinesis and poor outcome. A comprehensive and careful screening for disease‐causing genes and phenotype may help identify specific patients with left ventricular noncompaction and mortality‐related cardiac phenotypes.
- 4 November 2024
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 13 (21) , e035614
Open AccessDetermination of Genotype and Phenotypes in Pediatric Patients With Biventricular Noncompaction
Background: Left ventricular noncompaction (LVNC) is a hereditary type of cardiomyopathy characterized by prominent trabeculations. Detailed characteristics of biventricular noncompaction (BiVNC) remain unknown. This study aimed to elucidate the clinical characteristics and genetic landscape of BiVNC. Methods and Results: We recruited children with left ventricular noncompaction from Japanese multi‐institutional centers from 2013 to 2021. Left ventricular noncompaction was classified as BiVNC, congenital heart disease, arrhythmia, dilated cardiomyopathy, or normal function. In these patients, cardiomyopathy‐associated genes were screened. A total of 234 patients (127 male; mean age, 4 months [range, 0–6.6 years]) were enrolled in this study, of whom 25 had BiVNC; 55, normal function; 84, dilated cardiomyopathy; 38, congenital heart disease; and 32, arrhythmia. BiVNC was diagnosed during the perinatal period in 10 patients, in whom the prevalence was higher than that in other patients. A total of 14 patients in the group with BiVNC had congenital heart disease, but not necessarily right heart lesions. Left ventricular dyskinesis was frequently observed in the lateral wall (24%) and apex (28%). Eleven pathogenic variants were found in 11 patients with BiVNC (44.0%). The group with BiVNC had a higher ratio of mitochondrial and developmental gene variants than the other groups. Among all groups, the group with BiVNC had the worst survival rate ( P =0.0009). Conclusions: Pediatric patients with BiVNC had a high rate of ventricular dyskinesis and poor outcome. A comprehensive and careful screening for disease‐causing genes and phenotype may help identify specific patients with left ventricular noncompaction and mortality‐related cardiac phenotypes.
- 1 February 2023
- Published by Springer Nature in Heart and Vessels
- Vol. 38 (6) , 825-838
Assessment of left atrial deformation in patients with total anomalous pulmonary venous connection by two-dimensional speckle-tracking echocardiography
Background Total anomalous pulmonary venous connection (TAPVC) is a rare congenital heart disease of newborns characterized by impaired left ventricle growth and diastolic dysfunction. We hypothesized that the patients with TAPVC reduced blood flow into the left heart prenatally could affect left atrium (LA) not just growth but function. We compared the age-related changes in LA deformation using two-dimensional speckle-tracking echocardiography (2DSTE) in Patients with TAPVC. Method This single-center, retrospective cohort study was conducted on consecutive isolated TAPVC patients who underwent neonatal surgery between January 1, 2009 and January 1, 2022. The LA datasets in TAPVC patients were analyzed before surgery (n = 28) and follow-ups at 1−2 (n = 24) and 5−7 years of age (n = 13) and compared with those of age-matched healthy controls (January 2009−2022). The LA strain (ε), indicating LA function, was analyzed using QLAB represented by reservoir (εR), conduit (εCD), and contractile (εCT) strains. LA pressure was evaluated by periodic follow-up catheterization after repair. Results Compared to the controls, the TAPVC patients had significantly smaller LA maximum volume preoperatively, and with age, the LA maximal volumes reached normal levels, while the LA minimal volumes were larger. All 2DSTE-determined LA strains showed significant reductions at all time points in the TAPVC group compared to those in the control (median εR, εCD, and εCT; before surgery: 17.0% vs. 26.0%, 12.9% vs. 15.9%, and 6.3% vs. 10.4%; follow-up at 1−2 years: 30.0% vs. 45.7%, 23.2% vs. 29.6%, and 6.1% vs. 16.3%; follow-up at 5−7 years: 31.2% vs. 43.1%, 25.0% vs. 31.2%, and 5.2% vs. 10.8%, respectively; p < 0.05). Only εCT did not represented a significant change over time even though after correction of blood flow (median εCT: 6.0% → 5.9%). Patients with pulmonary venous obstruction (PVO) at birth showed significantly decreased εR and εCD and higher LA pressure compared to those without PVO. Conclusion This study showed that nevertheless maximum volume of LA was recovered within the normal range, reduced LA strains, especially contractile function lasted from birth even after repair in Patients with TAPVC.
- 1 February 2023
- Published by Springer Nature in Heart and Vessels
- Vol. 38 (6) , 825-838
Assessment of left atrial deformation in patients with total anomalous pulmonary venous connection by two-dimensional speckle-tracking echocardiography
Background Total anomalous pulmonary venous connection (TAPVC) is a rare congenital heart disease of newborns characterized by impaired left ventricle growth and diastolic dysfunction. We hypothesized that the patients with TAPVC reduced blood flow into the left heart prenatally could affect left atrium (LA) not just growth but function. We compared the age-related changes in LA deformation using two-dimensional speckle-tracking echocardiography (2DSTE) in Patients with TAPVC. Method This single-center, retrospective cohort study was conducted on consecutive isolated TAPVC patients who underwent neonatal surgery between January 1, 2009 and January 1, 2022. The LA datasets in TAPVC patients were analyzed before surgery (n = 28) and follow-ups at 1−2 (n = 24) and 5−7 years of age (n = 13) and compared with those of age-matched healthy controls (January 2009−2022). The LA strain (ε), indicating LA function, was analyzed using QLAB represented by reservoir (εR), conduit (εCD), and contractile (εCT) strains. LA pressure was evaluated by periodic follow-up catheterization after repair. Results Compared to the controls, the TAPVC patients had significantly smaller LA maximum volume preoperatively, and with age, the LA maximal volumes reached normal levels, while the LA minimal volumes were larger. All 2DSTE-determined LA strains showed significant reductions at all time points in the TAPVC group compared to those in the control (median εR, εCD, and εCT; before surgery: 17.0% vs. 26.0%, 12.9% vs. 15.9%, and 6.3% vs. 10.4%; follow-up at 1−2 years: 30.0% vs. 45.7%, 23.2% vs. 29.6%, and 6.1% vs. 16.3%; follow-up at 5−7 years: 31.2% vs. 43.1%, 25.0% vs. 31.2%, and 5.2% vs. 10.8%, respectively; p < 0.05). Only εCT did not represented a significant change over time even though after correction of blood flow (median εCT: 6.0% → 5.9%). Patients with pulmonary venous obstruction (PVO) at birth showed significantly decreased εR and εCD and higher LA pressure compared to those without PVO. Conclusion This study showed that nevertheless maximum volume of LA was recovered within the normal range, reduced LA strains, especially contractile function lasted from birth even after repair in Patients with TAPVC.
- Open Access
- 1 October 2021
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 42 (Supplement)
The impact of intraoperative pericardial three-dimensional echocardiography for the atrioventricular valve repair in the patient with congenital heart disease
Background: Atrioventricular valve (AVV) regurgitation enormously affected the survival outcome of the patients with congenital heart disease (CHD). However, the image quality by use of transthoracic echocardiography has not reached a level that is sufficient, and also, three-dimensional echocardiography, which is useful to clarify complex AVV anatomy, cannot be applied for the patients less than 15kg, to guide for the AVV repair in pediatric patients. We try to show surgeons more precise three-dimensional images about an AVV by using intraoperative pericardial three-dimensional echocardiography (IP3DE) and improve the surgical outcome. Purpose: To determine the efficacy of IP3DE by assessing the surgical outcome of an AVV repair and re-intervention rate. Method: Eighty-five patient with CHD who underwent atrioventricular repair with significant regurgitation (Grade 2–4+) before operation were divided into two groups imaged IP3DE or not, in our hospital from 1993 to 2020. We assessed the surgical outcome and re-intervention rate between two arms and re-evaluate AVV images before surgery compared to the IP3DE. Result: IP3DE was performed in forty-six patients (IP3DE group) and thirty-nine patients were not (control group). Median age at AVV repair was 3.0/2.8 years, respectively. The AVV was tricuspid (n=25), mitral (n=41), or common (n=19). The IP3DE group had a significantly higher improvement in regurgitation of AVV (IP3DE: Grade 3.2±0.3 → 1.7±0.3 vs Control: Grade 2.8±0.3 → 1.8±0.3, p<0.05). Fifty-nine percent of the IP3DE group was successful outcome (Grade<1+ after repair). There was no significant difference in the rate of re-intervention after surgery between two groups. In multivariate analysis, using IP3DE contributed to successful outcome for AVV repair (OR: 4.66, 95% CI: 1.46–14.8, p<0.01). The different and/or additional anatomical AVV findings were obtained in sixty-one percent of patients by the IP3DE. Conclusion: IP3DE contributes to successful outcome for AVV repair by obtaining further information on complicated AVV anatomy in congenital heart disease. IP3DE also enables both cardiovascular surgeons and cardiologists to share the accurate and detail “surgeon's view” in the operating room for planning of AVV repair. Funding Acknowledgement: Type of funding sources: None.
- 1 October 2021
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 42 (Supplement)
Open AccessThe impact of intraoperative pericardial three-dimensional echocardiography for the atrioventricular valve repair in the patient with congenital heart disease
Background: Atrioventricular valve (AVV) regurgitation enormously affected the survival outcome of the patients with congenital heart disease (CHD). However, the image quality by use of transthoracic echocardiography has not reached a level that is sufficient, and also, three-dimensional echocardiography, which is useful to clarify complex AVV anatomy, cannot be applied for the patients less than 15kg, to guide for the AVV repair in pediatric patients. We try to show surgeons more precise three-dimensional images about an AVV by using intraoperative pericardial three-dimensional echocardiography (IP3DE) and improve the surgical outcome. Purpose: To determine the efficacy of IP3DE by assessing the surgical outcome of an AVV repair and re-intervention rate. Method: Eighty-five patient with CHD who underwent atrioventricular repair with significant regurgitation (Grade 2–4+) before operation were divided into two groups imaged IP3DE or not, in our hospital from 1993 to 2020. We assessed the surgical outcome and re-intervention rate between two arms and re-evaluate AVV images before surgery compared to the IP3DE. Result: IP3DE was performed in forty-six patients (IP3DE group) and thirty-nine patients were not (control group). Median age at AVV repair was 3.0/2.8 years, respectively. The AVV was tricuspid (n=25), mitral (n=41), or common (n=19). The IP3DE group had a significantly higher improvement in regurgitation of AVV (IP3DE: Grade 3.2±0.3 → 1.7±0.3 vs Control: Grade 2.8±0.3 → 1.8±0.3, p<0.05). Fifty-nine percent of the IP3DE group was successful outcome (Grade<1+ after repair). There was no significant difference in the rate of re-intervention after surgery between two groups. In multivariate analysis, using IP3DE contributed to successful outcome for AVV repair (OR: 4.66, 95% CI: 1.46–14.8, p<0.01). The different and/or additional anatomical AVV findings were obtained in sixty-one percent of patients by the IP3DE. Conclusion: IP3DE contributes to successful outcome for AVV repair by obtaining further information on complicated AVV anatomy in congenital heart disease. IP3DE also enables both cardiovascular surgeons and cardiologists to share the accurate and detail “surgeon's view” in the operating room for planning of AVV repair. Funding Acknowledgement: Type of funding sources: None.
- 1 January 2021
- Published by Japanese Pharmacological Society in Folia Pharmacologica Japonica
- Vol. 156 (6) , 345
序文
- 1 January 2021
- Published by Japanese Pharmacological Society in Folia Pharmacologica Japonica
- Vol. 156 (6) , 345
序文
- Open Access
- 13 May 2020
- Published by Springer Nature in Surgical Case Reports
- Vol. 6 (1) , 1-5
Adverse impact of univentricular pacing for the patient with functional single ventricle: successful conversion to cardiac resynchronization therapy
Background: In a Fontan candidate, univentricular pacing may cause delay in interventricular conduction, which induces asynchronous contraction. Cardiac resynchronization therapy is expected to be an effective mode of therapy in such a case. Case presentation: A 7-month-old girl, diagnosed with dextrocardia, congenitally corrected transposition of the great artery [situs solitus, L-loop, and L-transposition], ventricular septal defect, infundibular and pulmonary valvular stenosis, and straddling of the tricuspid valve, was considered as a candidate for the Fontan procedure. She had undergone Blalock-Taussig shunt, and epicardial univentricular pacemaker implantation for persistent complete atrioventricular block. She underwent a bidirectional cavopulmonary shunt concomitant with ventricular lead translocation from the morphological left ventricle to the morphological right ventricle. After discharge, ventricular dyssynchrony was noted and cardiac failure persisted. She was converted to cardiac resynchronization therapy (CRT) at 13 months of age. Two-dimensional speckle tracking imaging was used by cardiologists to determine the most suitable pacing site. CRT rapidly corrected the heart failure; thus, she underwent the Fontan procedure after 1.5 years. Five years have passed since the cardiac resynchronization therapy; her interventricular synchrony is maintained well and the level of brain natriuretic peptide remains within normal range. Conclusion: We describe the successful conversion from single ventricular pacing to CRT, in a case of congenitally corrected transposition of the great artery indicated for the Fontan procedure. The long-term prognosis of cardiac resynchronization therapy is undetermined in the pediatric population; therefore, further follow-up is required.
- 13 May 2020
- Published by Springer Nature in Surgical Case Reports
- Vol. 6 (1) , 1-5
Open AccessAdverse impact of univentricular pacing for the patient with functional single ventricle: successful conversion to cardiac resynchronization therapy
Background: In a Fontan candidate, univentricular pacing may cause delay in interventricular conduction, which induces asynchronous contraction. Cardiac resynchronization therapy is expected to be an effective mode of therapy in such a case. Case presentation: A 7-month-old girl, diagnosed with dextrocardia, congenitally corrected transposition of the great artery [situs solitus, L-loop, and L-transposition], ventricular septal defect, infundibular and pulmonary valvular stenosis, and straddling of the tricuspid valve, was considered as a candidate for the Fontan procedure. She had undergone Blalock-Taussig shunt, and epicardial univentricular pacemaker implantation for persistent complete atrioventricular block. She underwent a bidirectional cavopulmonary shunt concomitant with ventricular lead translocation from the morphological left ventricle to the morphological right ventricle. After discharge, ventricular dyssynchrony was noted and cardiac failure persisted. She was converted to cardiac resynchronization therapy (CRT) at 13 months of age. Two-dimensional speckle tracking imaging was used by cardiologists to determine the most suitable pacing site. CRT rapidly corrected the heart failure; thus, she underwent the Fontan procedure after 1.5 years. Five years have passed since the cardiac resynchronization therapy; her interventricular synchrony is maintained well and the level of brain natriuretic peptide remains within normal range. Conclusion: We describe the successful conversion from single ventricular pacing to CRT, in a case of congenitally corrected transposition of the great artery indicated for the Fontan procedure. The long-term prognosis of cardiac resynchronization therapy is undetermined in the pediatric population; therefore, further follow-up is required.
- Open Access
- 10 June 2016
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 18 (suppl_1) , i147
216-23: A prospective multicenter, open-label study of landiolol for tachyarrhythmias in children: Control of the HEART rate in inFant and child arrhythmias Using Landiolol (HEARTFUL) study
Introduction: Persistent tachycardia in pediatric patients with heart failure sometimes deteriorates their hemodynamic condition, which requires immediate intervention to control their heart rate. Particularly, tachyarrhythmias after congenital heart surgery may sometimes become fatal. In Japan, there are only a few intravenous anti-arrhythmic agents that have been approved to control pediatric arrhythmias. Although, treatment of tachyarrhythmias in young patients with cardiac dysfunction are mandatory, there are no approved medications to treat them in these patients. Consequently, novel and effective medications for these patients are required. Landiolol, an ultra-short-acting beta-blocker was approved in 2013 for tachyarrhythmias in adult patients with cardiac dysfunction. However, its efficacy and safety in pediatrics remain unknown. Methods: This study is a phase IIb/phase III study to investigate the efficacy and safety of landiolol in pediatric patients with tachyarrhythmias (atrial fibrillation, atrial flutter, and supraventricular tachycardia) and heart failure. This study was designed as a prospective multicenter open-label study. Successful heart rate control was defined as a ≥20% reduction in the heart rate or conversion to normal sinus rhythm within 2hr after starting the intravenous administration of landiolol. This study was started in April 2015 and will end within a few years. Conclusion: The data from the HEARTFUL study may establish the efficacy and safety of landiolol for various tachyarrhythmias in pediatric patients, even if the patients have cardiac dysfunction.
- 10 June 2016
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 18 (suppl_1) , i147
Open Access216-23: A prospective multicenter, open-label study of landiolol for tachyarrhythmias in children: Control of the HEART rate in inFant and child arrhythmias Using Landiolol (HEARTFUL) study
Introduction: Persistent tachycardia in pediatric patients with heart failure sometimes deteriorates their hemodynamic condition, which requires immediate intervention to control their heart rate. Particularly, tachyarrhythmias after congenital heart surgery may sometimes become fatal. In Japan, there are only a few intravenous anti-arrhythmic agents that have been approved to control pediatric arrhythmias. Although, treatment of tachyarrhythmias in young patients with cardiac dysfunction are mandatory, there are no approved medications to treat them in these patients. Consequently, novel and effective medications for these patients are required. Landiolol, an ultra-short-acting beta-blocker was approved in 2013 for tachyarrhythmias in adult patients with cardiac dysfunction. However, its efficacy and safety in pediatrics remain unknown. Methods: This study is a phase IIb/phase III study to investigate the efficacy and safety of landiolol in pediatric patients with tachyarrhythmias (atrial fibrillation, atrial flutter, and supraventricular tachycardia) and heart failure. This study was designed as a prospective multicenter open-label study. Successful heart rate control was defined as a ≥20% reduction in the heart rate or conversion to normal sinus rhythm within 2hr after starting the intravenous administration of landiolol. This study was started in April 2015 and will end within a few years. Conclusion: The data from the HEARTFUL study may establish the efficacy and safety of landiolol for various tachyarrhythmias in pediatric patients, even if the patients have cardiac dysfunction.